| Authors: |
Rossignol P; Université de Lorraine, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigations Cliniques-Plurithématique 1433, INSERM Unit 1116, Centre Hospitalier Régional Universitaire (CHRU) de Nancy, and French Clinical Research Infrastructure Network Investigator Network initiative Cardiovascular and Renal Clinical Trialists (F-CRIN INI-CRCT), Nancy, France (P.R.).; Medical specialties and nephrology departments, Princess Grace Hospital, and Monaco Private Hemodialysis Centre, Monaco, and Monaco Clinical Research Infrastructure Network (M-CRIN), Monaco (P.R.)., Clozel M; Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland (M.C.)., Dreier RF; Novartis Pharmaceuticals AG, Basel, Switzerland (R.F.D.)., Flack JM; Division of General Internal Medicine, Hypertension Section, Department of Medicine, Hypertension Section, Southern Illinois University School of Medicine, Springfield, IL (J.M.F.)., Flamion B; Viatris Innovation GmbH, Allschwil, Switzerland (B.F., M.S.-S.)., Mann J; Department of Medicine, Universitätsklinikum Erlangen, Germany (J.M.).; Outpatient Clinic, KfH Kidney Centre, Munich, Germany (J.M.)., Narkiewicz K; Department of Hypertension and Diabetology, Medical University of Gdańsk, Poland (K.N.)., Sassi-Sayadi M; Viatris Innovation GmbH, Allschwil, Switzerland (B.F., M.S.-S.)., Wang JG; Department of Hypertension, The Shanghai Institute of Hypertension, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, China (J.-G.W.)., Weber MA; Division of Cardiovascular Medicine, Downstate College of Medicine, State University of New York, Brooklyn (M.A.W.)., Schlaich MP; Dobney Hypertension Centre, Royal Perth Hospital Research Foundation, Medical School, University of Western Australia, Perth, Australia (M.P.S.).; Department of Cardiology and Department of Nephrology, Royal Perth Hospital, WA, Australia (M.P.S.). |
